Management of simple nodular goiter: Current status and future perspectives

Endocrine Reviews

Volumn 24, Issue 1, 2003, Pages 102-132

  Hegedüs, Laszlo ^a   Bonnema, Steen J ^a   Bennedbæk, Finn N ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; IODINE 131; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROXINE;

ASPIRATION BIOPSY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DYSPHONIA; FIBROSIS; HEMATOMA; HUMAN; HYPERPYREXIA; LOW LEVEL LASER THERAPY; MEDICAL ASSESSMENT; MORPHOLOGY; NODULAR GOITER; PAIN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RETROSTERNAL GOITER; REVIEW; THROMBOSIS;

BIOPSY, NEEDLE; CALCITONIN; DIAGNOSTIC IMAGING; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; SURGICAL PROCEDURES, OPERATIVE; THYROID HORMONES; THYROXINE;

EID: 0037323540     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2002-0016     Document Type: Review

References (359)

1. Hegedüs L, Gerber H 2000 Multinodular goiter. In: de Groot LJ, Jameson JL, eds. Endocrinology. Philadelphia: WB Saunders: 1517-1528
2. Jarløv AE, Nygaard B, Hegedüs L, Hartling SG, Hansen JM 1998 Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid 8:393-398
3. Giuffrida D, Gharib H 1995 Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 99:642-650
4. Hegedüs L 2001 Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339-360
5. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ 2000 Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133: 696-700
6. Bennedbæk FN, Perrild H, Hegedüs L 1999 Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 50:357-363
7. Bennedbæk FN, Hegedüs L 2000 Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 85:2493-2498
8. Bonnema SJ, Bennedbæk FN, Wiersinga WM, Hegedüs L 2000 Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 53:5-12
9. Bonnema SJ, Bennedbæk FN, Ladenson PW, Hegedüs L 2002 Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 87:112-117
10. Hegedüs L 2000 Nonisotopic techniques of thyroid imaging. In: Braverman LE, Utiger R, eds. The thyroid: a fundamental and clinical text. Philadelphia: Lippincott, Williams and Williams; 432-440
11. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
12. Toft AD 2001 Clinical practice Subclinical hyperthyroidism. N Engl J Med 345:512-516
13. Derwahl M, Broecker M, Kraiem Z 1999 Clinical review 101: thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 84:829-834
14. Derwahl M, Studer H 2000 Multinodular goitre: 'much more to it than simply iodine deficiency'. Baillieres Clin Endocrinol Metab 14:577-600
15. Studer H, Derwahl M 1995 Mechanisms of nonneoplastic endocrine hyperplasia-a changing concept: a review focused on the thyroid gland. Endocr Rev 16:411-426
16. Meier CA 2000 Thyroid nodules: pathogenesis, diagnosis and treatment. Baillieres Clin Endocrinol Metab 14:559-575
17. Krohn K, Paschke R 2001 Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86:3336-3345
18. Brix TH, Hegedüs L 2000 Genetic and environmental factors in the aetiology of simple goitre. Ann Med 32:153-156
19. Samuels MH 2001 Evaluation and treatment of sporadic nontoxic goiter-some answers and more questions. J Clin Endocrinol Metab 86:994-997
20. Franklyn JA 2000 Lack of consensus in Europe in the management of multinodular goitre. Clin Endocrinol (Oxf) 53:3-4
21. Brix TH, Kyvik KO, Hegedüs L 1999 Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab 84:3071-3075
22. Brix TH, Kyvik KO, Hegedüs L 2000 A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85:536-539
23. Brix TH, Kyvik KO, Christensen K, Hegedüs L 2001 Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930-934
24. Medeiros-Neto G 2000 Iodine deficiency disorders. In: de Groot LJ, Jameson JL, eds. Endocrinology. Philadelphia: WB Saunders; 1529-1539
25. Hegedüs L 1990 Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan Med Bull 37:249-263
26. Bertelsen JB, Hegedüs L 1994 Cigarette smoking and the thyroid. Thyroid 4:327-331
27. Brix TH, Hansen PS, Kyvik KO, Hegedüs L 2000 Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med 160:661-666
28. Gaitan E 2000 Environmental natural goitrogens. In: Peter F, Wiersinga WM, Hostalek U, eds. The thyroid and environment. New York: Schattauer; 69-78
29. Orenstein H, Peskind A, Raskind MA 1988 Thyroid disorders in female psychiatric patients with panic disorder or agoraphobia. Am J Psychiatry 145:1428-1430
30. Gittoes NJ, Franklyn JA, Sarne OH, Refetoff S, Sheppard MC 2000 Iodine deficiency disorders. In: de Groot LJ, Jameson JL, eds. Endocrinology. Philadelphia: WB Saunders, 1361-1398
31. Surks MI, Sievert R 1995 Drugs and thyroid function. N Engl J Med 333:1688-1694
32. Farwell AP, Braverman LE 1996 Inflammatory thyroid disorders. Otolaryngol Clin North Am 29:541-556
33. Knudsen N, Bülow I, Laurberg P, Perrild H, Ovesen L, Jørgensen T 2001 Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol (Oxf) 55: 41-46
34. Hegedüs L, Rasmussen N, Ravn V, Kastrup J, Krogsgaard K, Aldershvile J 1988 Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism 37:229-233
35. Malamos B, Koutras DA, Kostamis P, Kralios AC, Rigopoulos G, Zerefos N 1966 Endemic goiter in Greece: epidemiologic and genetic studies. J Clin Endocrinol Metab 26:688-695
36. Bartels ED 1941 Heredity in Graves' disease. With remarks on heredity in toxic adenoma in the thyroid, non-toxic goitre and myxoedema. Dissertation, University of Copenhagen
37. Martin L, Fisher RA 1945 The hereditary and familial aspects of exophthalmic goitre and nodular goitremic. Q J Med 14:207-219
38. Malamos B, Koutras DA, Kostamis P, Rigopoulos GA, Zerefos NS, Yataganas XA 1967 Endemic goitre in Greece: a study of 379 twin pairs. J Med Genet 4:16-18
39. Greig WR, Boyle JA, Duncan A, Nicol J, Gray MJ, Buchanan WW, McGirr EM 1967 Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. Q J Med 36:175-188
40. Corral J, Martin C, Perez R, Sanchez I, Mories MT, San Millan JL, Miralles JM, Gonzalez-Sarmiento R 1993 Thyroglobulin gene point mutation associated with non-endemic simple goitre. Lancet 341:462-464
41. Neumann S, Willgerodt H, Ackermann F, Reske A, Jung M, Reis A, Paschke R 1999 Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter. J Clin Endocrinol Metab 84:3750-3756
42. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD 1997 Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-1130
43. McKay JD, Williamson J, Lesueur F, Stark M, Duffield A, Canzian F, Romeo G, Hoffman L 1999 At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family. Eur J Endocrinol 141:122-125
44. Capon F, Tacconelli A, Giardina E, Sciacchitano S, Bruno R, Tassi V, Trischitta V, Filetti S, Dallapiccola B, Novelli G 2000 Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet 67:1004-1007
45. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF 1997 Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 82:1645-1648
46. Wang C, Crapo LM 1997 The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26: 189-218
47. Berghout A, Wiersinga WM, Smits NJ, Touber JL 1987 Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clin Endocrinol (Oxf) 26:273-280
48. Gutekunst R, Smolarek H, Hasenpusch U, Stubbe P, Friedrich HJ, Wood WG, Scriba PC 1986 Goitre epidemiology: thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) 112:494-501
49. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jørgensen T 2000 Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 142:224-230
50. Nygaard B, Gideon P, Dige-Petersen H, Jespersen N, Sølling K, Veje A 1993 Thyroid volume and morphology and urinary iodine excretion in a Danish municipality. Acta Endocrinol (Copenh) 129: 505-510
51. Knudsen N, Büllow I, Jørgensen T, Laurberg P, Ovesen L, Perrild H 2000 Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 53:479-485
52. Laurberg P, Pedersen IB, Knudsen N, Ovesen L, Andersen S 2001 Environmental iodine intake affects the type of non-malignant thyroid disease. Thyroid 11:457-469
53. Li M, Liu DR, Qu CY, Zhang PY, Qian QD, Zhang CD, Jia QZ, Wang HX, Eastman CJ, Boyages SC 1987 Endemic goitre in central China caused by excessive iodine intake. Lancet 2:257-259
54. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481-493
55. Vander JB, Gaston EA, Dawber TR 1954 Significance of solitary nontoxic thyroid nodules. Preliminary report. N Engl J Med 251.970
56. Baldwin DB, Rowett D 1978 Incidence of thyroid disorders in Connecticut. JAMA 239:742-744
57. Vander JB, Gaston EA, Dawber TR 1968 The significance of non-toxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537-540
58. Jarløv AE, Hegedüs L, Gjørup T, Hansen JM 1991 Observer variation in the clinical assessment of the thyroid gland. J Intern Med 229:159-161
59. Jarløv EA, Hegedüs L, Gjørup T, Hansen MJ 1992 Inadequacy of the WHO classification of the thyroid gland. Thyroidology 4: 107-110
60. Brander A, Viikinkoski P, Nickels J, Kivisaari L 1991 Thyroid gland: US screening in a random adult population. Radiology 181: 683-687
61. Tan GH, Gharib H 1997 Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226-231
62. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363-369
63. Mortensen JD, Woolner LB, Bennett WA 1955 Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270-1280
64. Ashcraft MW, Van Herle AJ 1981 Management of thyroid nodules. I. History and physical examination, blood tests, x-ray tests, and ultrasonography. Head Neck Surg 3:216-230
65. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, Hegedüs L 1999 The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 84:3636-3641
66. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Hasan DM, Rodgers H, Tunbridge F 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
67. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W 1991 Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 91:363-370
68. Berghout A, Wiersinga WM, Smits NJ, Touber JL 1990 Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602-608
69. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL 1990 Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 336: 193-197
70. Wesche MF, Wiersinga WM, Smits NJ 1998 Lean body mass as a determinant of thyroid size. Clin Endocrinol (Oxf) 48:701-706
71. Andersen-Ranberg K, Jeune B, Høier-Madsen M, Hegedüs L 1999 Thyroid function, morphology and prevalence of thyroid disease in a population-based study of Danish centenarians. J Am Geriatr Soc 47:1238-1243
72. Støving RK, Bennedbæk FN, Hegedüs L, Hagen C 2001 Evidence of diffuse atrophy of the thyroid gland in patients with anorexia nervosa. Int J Eat Disord 29:230-235
73. Dormitzer PR, Ellison PT, Bode HH 1989 Anomalously low endemic goiter prevalence among Efe pygmies. Am J Phys Anthropol 78:527-531
74. Furlanetto TW, Nguyen LQ, Jameson JL 1999 Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140:5705-5711
75. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Morita S, Miyauchi A, Katayama S, Sugawara M 1992 Outcome of long standing solitary thyroid nodules. World J Surg 16:583-587
76. Gemsenjager E, Staub JJ, Girard J, Heitz P 1976 Preclinical hyperthyroidism in multinodular goiter. J Clin Endocrinol Metab 43:810-816
77. Elte JW, Bussemaker JK, Haak A 1990 The natural history of euthyroid multinodular goitre. Postgrad Med J 66:186-190
78. Wiener JD, de Vries AA 1979 On the natural history of Plummer's disease. Clin Nucl Med 4:181-190
79. Belfiore A, Sava L, Runello F, Tomaselli L, Vigneri R 1983 Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metab 56:283-287
80. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D 1993 Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 128:51-55
81. Hamburger JI 1980 Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 50:1089-1093
82. Blum M, Biller BJ, Bergman DA 1974 The thyroid cork. Obstruction of the thoracic inlet due to retroclavicular goiter. JAMA 227: 189-191
83. Wallace C, Siminoski K 1996 The Pemberton sign. Ann Intern Med 125:568-569
84. Shaha AR, Alfonso AE, Jaffe BM 1989 Operative treatment of substernal goiters. Head Neck 11:325-330
85. Katlic MR, Grillo HC, Wang CA 1985 Substernal goiter. Analysis of 80 patients from Massachusetts General Hospital. Am J Surg 149:283-287
86. Netterville JL, Coleman SC, Smith JC, Smith MM, Day TA, Burkey BB 1998 Management of substernal goiter. Laryngoscope 108: 1611-1617
87. Moron JC, Singer JA, Sardi A 1998 Retrosternal goiter: a six-year institutional review. Am Surg 64:889-893
88. Meysman M, Noppen M, Vincken W 1996 Effect of posture on the flow-volume loop in two patients with euthyroid goiter. Chest 110:1615-1618
89. Shaha A, Alfonso A, Jaffe BM 1987 Acute airway distress due to thyroid pathology. Surgery 102:1068-1074
90. Melliere D, Saada F, Etienne G, Becquemin JP, Bonnet F 1988 Goiter with severe respiratory compromise: evaluation and treatment. Surgery 103:367-373
91. Gittoes NJ, Miller MR, Daykin J, Sheppard MC, Franklyn JA 1996 Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement. Br Med J 312:484
92. Anders HJ 1998 Compression syndromes caused by substernal goitres. Postgrad Med J 74:327-329
93. van Doorn LG, Kranendonk SE 1996 Partial unilateral phrenic nerve paralysis caused by a large intrathoracic goitre. Neth J Med 48:216-219
94. Gurlek A, Usman A, Bayraktar M, Ozenc A 2000 Horner's syndrome: recovery after surgical excision of intrathoracic benign multinodular goiter. Endocr J 47:643-644
95. Rieu M, Bekka S, Sambor B, Berrod JL, Fombeur JP 1993 Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre. Clin Endocrinol (Oxf) 39:67-71
96. Jarløv AE, Hegedüs L, Gjørup T, Hansen JE 1991 Accuracy of the clinical assessment of thyroid size. Dan Med Bull 38:87-89
97. Hegedüs L, Karstrup S, Rasmussen N 1986 Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol 155:142-145
98. Buckels JA, Webb AM, Rhodes A 1983 Is paroxysmal thyroid swelling due to phaeochromocytoma a forgotten physical sign? Br Med J (Clin Res Ed) 287:1206-1207
99. Loh KC 1997 Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113
100. Refetoff S, Harrison J, Karanfilski BT, Kaplan EL, de Groot LJ, Bekerman C 1975 Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 292:171-175
101. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S 2001 15 Years after Chernobyl: new evidence of thyroid cancer. Lancet 358:1965-1966
102. Rieger R, Pimpl W, Money S, Rettenbacher L, Galvan G 1989 Hyperthyroidism and concurrent thyroid malignancies. Surgery 106:6-10
103. Hamming JF, Goslings BM, van Steenis GJ, van Ravenswaay CH, Hermans J, van de Velde CJ 1990 The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 150:113-116
104. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR 1998 iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83:765-769
105. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A 1999 The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566
106. Nygaard B, Knudsen JH, Hegedüs L, Veje A, Hansen JE 1997 Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 82:2926-2930
107. Feldt-Rasmussen U, Bech K, Date J 1979 Serum thyroglobulin in patients with toxic and non-toxic goitres compared to sex- and age-matched control subjects. Acta Endocrinol (Copenh) 91: 264-270
108. Date J, Feldt-Rasmussen U, Blichert-Toft M, Hegedüs L, Graversen HP 1996 Long-term observation of serum thyroglobulin after resection of nontoxic goiter and relation to ultrasonographically demonstrated relapse. World J Surg 20:351-356
109. Cohen R, Campos JM, Salaun C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E 2000 Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919-922
110. Uwaifo GI, Remaley AT, Stene M, Reynolds JC, Yen PM, Snider RH, Becker KL, Sarlis NJ 2001 A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Invest 24:361-369
111. Tommasi M, Brocchi A, Cappellini A, Raspanti S, Mannelli M 2001 False serum calcitonin high levels using a non-competitive two-site IRMA. J Endocrinol Invest 24:356-360
112. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH 2001 Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11:73-80
113. Grauer A, Raue F, Ziegler R 1998 Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes 106:353-359
114. Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, Soeregi G, Niederle B, Vierhapper H 1999 Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 9:943-947
115. Vlaeminck-Guillem V, D'herbomez M, Pigny P, Fayard A, Bauters C, Decoulx M, Wemeau JL 2001 Pseudohypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab 86:3091-3096
116. Erdogan MF, Guellue S, Baskal N, Uysal AR, Kamel N, Erdogan G 1997 Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 82:897-899
117. Marsh DJ, Mulligan LM, Eng C 1997 RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Horm Res 47:168-178
118. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593
119. Rude RK, Singer FR 1977 Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 44:980-983
120. Kaserer K, Scheuba C, Neuhold N, Weinhaeusel A, Vierhapper H, Haas OA, Niederle B 1998 C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722-728
121. Gibson WC, Peng TC, Croker BP 1981 C-cell nodules in adult human thyroid. A common autopsy finding. Am J Clin Pathol 75:347-350
122. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 42:453-460
123. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 82:338-341
124. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829
125. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tuzun M, Yetkin E, Tuncyurek M, Kabalak T 1999 Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid 9:579-582
126. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG 1996 Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165-2172
127. 2001 AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202-220
128. Tan GH, Gharib H, Reading CC 1995 Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med 155:2418-2423
129. Berghout A, Wiersinga WM, Smits NJ, Touber JL 1988 The value of thyroid volume measured by ultrasonography in the diagnosis of goitre. Clin Endocrinol (Oxf) 28:409-414
130. Gharib H, Goellner JR 1993 Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289
131. Knudsen N, Bols B, Bülow I, Jørgensen T, Perrild H, Ovesen L, Laurberg P 1999 Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9:1069-1074
132. Wiest PW, Hartshorne MF, Inskip PD, Crooks LA, Vela BS, Telepak RJ, Williamson MR, Blumhardt R, Bauman JM, Tekkel M 1998 Thyroid palpation vs. high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 17:487-496
133. Ezzat S, Sarti DA, Cain DR, Braunstein GD 1994 Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838-1840
134. Tomimori E, Pedrinola F, Cavaliere H, Knobel M, Medeiros-Neto G 1995 Prevalence of incidental thyroid disease in a relatively low iodine intake area. Thyroid 5:273-276
135. Brander A, Viikinkoski P, Nickels J, Kivisaari L 1989 Thyroid gland: US screening in middle-aged women with no previous thyroid disease. Radiology 173:507-510
136. Asanuma K, Kobayashi S, Shingu K, Hama Y, Yokoyama S, Fujimori M, Amano J 2001 The rate of tumour growth does not distinguish between malignant and benign thyroid nodules. Eur J Surg 167:102-105
137. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC 1981 [Volumetric analysis of thyroid lobes by real-time ultrasound.] Dtsch Med Wochenschr 106:1338-1340
138. Reinartz P, Sabri O, Zimny M, Nowak B, Cremerius U, Setani K, Bull U 2002 Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography. Thyroid 12:713-717
139. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM 1983 The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260-263
140. Nygaard B, Nygaard T, Court-Payen, Jensen LI, Soe-Jensen P, Gerhard NK, Fugl M, Hegedus L 2002 Thyroid volume measured by ultrasonography and CT. Acta Radiol 43:269-274
141. Bonnema SJ, Andersen PB, Knudsen DU, Hegedüs L 2002 MR imaging of large multinodular goiters: observer agreement on volume vs. observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol 179:259-266
142. Schlogl S, Werner E, Lassmann M, Terekhova J, Muffert S, Seybold S, Reiners C 2001 The use of three-dimensional ultrasound for thyroid volumetry. Thyroid 11:569-574
143. Wanet PM, Sand A, Abramovici J 1996 Physical and clinical evaluation of high-resolution thyroid pinhole tomography. J Nucl Med 37:2017-2020
144. Ramos CD, Zantut-Wittmann DE, Tambascia MA, Assumpcao L, Etchebehere EC, Camargo EE 2000 Thyroid suppression test with L-thyroxine and [99 mTc] pertechnetate. Clin Endocrinol (Oxf) 52: 471-477
145. Hoving J, Piers DA, Vermey A, Oosterhuis JW 1981 Carcinoma in hyperfunctioning thyroid nodule in recurrent hyperthyroidism. Eur J Nucl Med 6:131-132
146. Hays MT, Wesselossky B 1973 Simultaneous measurement of thyroidal trapping (99 mTcO4-) and binding (131I-): clinical and experimental studies in man. J Nucl Med 14:785-792
147. Arnold JE, Pinsky S 1976 Comparison of 99 mTc and 123I for thyroid imaging. J Nucl Med 17:261-267
148. Dige-Petersen H, Kroon S, Vadstrup S, Andersen ML, Roy-Poulsen NO 1978 A comparison of 99Tc and 123I scintigraphy in nodular thyroid disorders. Eur J Nucl Med 3:1-4
149. Ryo UY, Vaidya PV, Schneider AB, Bekerman C, Pinsky SM 1983 Thyroid imaging agents: a comparison of I-123 and Tc-99m pertechnetate. Radiology 148:819-822
150. Kumar A, Ahuja MM, Chattopadhyay TK, Padhy AK, Gupta AK, Kapila K, Goel AK, Karmarker MG 1992 Fine needle aspiration cytology, sonography and radionuclide scanning in solitary thyroid nodule. J Assoc Physicians India 40:302-306
151. Loy TJ, Sundram FX 1989 Diagnostic management of solitary thyroid nodules. Ann Acad Med Singapore 6:658-664
152. Ashcraft MW, Van Herle AJ 1981 Management of thyroid nodules. II. Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg 3:297-322
153. Christensen SB, Bondeson L, Ericsson UB, Lindholm K 1984 Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin. A prospective study of 100 surgically treated patients. Acta Chir Scand 150:433-439
154. Cox MR, Marshall SG, Spence RA 1991 Solitary thyroid nodule: a prospective evaluation of nuclear scanning and ultrasonography. Br J Surg 78:90-93
155. Oommen R, Walter NM, Tulasi NR 1994 Scintigraphic diagnosis of thyroid cancer. Correlation of thyroid scintigraphy and histopathology. Acta Radiol 35:222-225
156. Okumura Y, Takeda Y, Sato S, Komatsu M, Nakagawa T, Akaki S, Kuroda M, Joja I, Hiraki Y 1999 Comparison of differential diagnostic capabilities of 201T1 scintigraphy and fine-needle aspiration of thyroid nodules. J Nucl Med 40:1971-1977
157. Sinha PS, Beeby DI, Ryan P 2001 An evaluation of thallium imaging for detection of carcinoma in clinically palpable solitary, nonfunctioning thyroid nodules. Thyroid 11:85-89
158. Kresnik E, Gallowitsch HJ, Mikosch P, Gomez I, Lind P 1997 Technetium-99 m-MIBI scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med 38:62-65
159. Sathekge MM, Mageza RB, Muthuphei MN, Modiba MC, Clauss RC 2001 Evaluation of thyroid nodules with technetium-99 m MIBI and technetium-99m pertechnetate. Head Neck 23:305-310
160. Wesche MF, Tiel-Van Buul MM, Smits NJ, Wiersinga WM 1998 Ultrasonographic vs. scintigraphic measurement of thyroid volume in patients referred for 131I therapy. Nucl Med Commun 19: 341-346
161. Huysmans DA, de Haas MM, van den Broek WJ, Hermus AR, Barentsz JO, Corstens FH, Ruijs SH 1994 Magnetic resonance imaging for volume estimation of large multinodular goitres: a comparison with scintigraphy. Br J Radiol 67:519-523
162. de Klerk JM, Van Isselt JW, van Dijk A, Hakman ME, Pameijer FA, Koppeschaar HP, Zelissen PM, van Schaik JP, Van Rijk PP 1997 Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 38:372-376
163. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559
164. Jennings A 2001 Evaluation of substernal goiters using computed tomography and MR imaging. Endocrinol Metab Clin North Am 30:401-414
165. Belardinelli L, Gualdi G, Ceroni L, Guadalaxara A, Polettini E, Pappalardo G 1995 Comparison between computed tomography and magnetic resonance data and pathologic findings in substernal goiters. Int Surg 80:65-69
166. Hermans R, Bouillon R, Laga K, Delaere PR, Foer BD, Marchal G, Baert AL 1997 Estimation of thyroid gland volume by spiral computed tomography. Eur Radiol 7:214-216
167. Bloom AD, Adler LP, Shuck JM 1993 Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114:728-734
168. Uematsu H, Sadato N, Ohtsubo T, Tsuchida T, Nakamura S, Sugimoto K, Waki A, Takahashi N, Yonekura Y, Tsuda G, Saito H, Hayashi N, Yamamoto K, Ishii Y 1998 Fluorine-18-fluorodeoxyglucose PET vs. thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39:453-459
169. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF 2001 Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941-946
170. Jauregui R, Lilker ES, Bayley A 1977 Upper airway obstruction in euthyroid goiter. JAMA 238:2163-2166
171. Geraghty JG, Coveney EC, Kiernan M, O'Higgins NJ 1992 Flow volume loops in patients with goiters. Ann Surg 215:83-86
172. Thusoo TK, Gupta U, Kochhar K, Hira HS 2000 Upper airway obstruction in patients with goiter studies by flow volume loops and effect of thyroidectomy. World J Surg 24:1570-1572
173. Melissant CF, Smith SJ, Perlberger R, Verschakelen J, Lammers JW, Demedts M 1994 Lung function, CT-scan and x-ray in upper airway obstruction due to thyroid goitre. Eur Respir J 7:1782-1787
174. Huysmans DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW 1994 Large, compressive goiters treated with radioiodine. Ann Intern Med 121:757-762
175. Hoffstein V 1986 Relationship between lung volume, maximal expiratory flow, forced expiratory volume in one second, and tracheal area in normal men and women. Am Rev Respir Dis 134: 956-961
176. Brown IG, Webster PM, Zamel N, Hoffstein V 1986 Changes in tracheal cross-sectional area during Mueller and Valsalva maneuvers in humans. J Appl Physiol 60:1865-1870
177. Fouke JM, Strohl KP 1987 Effect of position and lung volume on upper airway geometry. J Appl Physiol 63:375-380
178. Korun N, Asci C, Yilmazlar T, Duman H, Zorluoglu A, Tuncel E, Erturk E, Yerci O 1997 Total thyroidectomy or lobectomy in benign nodular disease of the thyroid: changing trends in surgery. Int Surg 82:417-419
179. Burch HB 1995 Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 24:663-710
180. Cochand-Priollet B, Guillausseau PJ, Chagnon S, Hoang C, Guillausseau-Scholer C, Chanson P, Dahan H, Warnet A, Tran Ba Huy PT, Valleur P 1994 The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings. Am J Med 97:152-157
181. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A 1998 Diagnostic accuracy of conventional vs. sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 8:15-21
182. Goellner JR, Gharib H, Grant CS, Johnson DA 1987 Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 31: 587-590
183. Yang GC, Liebeskind D, Messina AV 2001 Ultrasound-guided fine-needle aspiration of the thyroid assessed by Ultrafast Papanicolaou stain: data from 1135 biopsies with a two- to six-year follow-up. Thyroid 11:581-589
184. Hamburger JI 1994 Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 79:335-339
185. Dwarakanathan AA, Staren ED, D'Amore MJ, Kluskens LF, Martirano M, Economou SG 1993 Importance of repeat fine-needle biopsy in the management of thyroid nodules. Am J Surg 166: 350-352
186. Gharib H, Goellner JR, Zinsmeister AR, Grant CS, van Heerden JA 1984 Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med 101:25-28
187. Busseniers AE, Oertel YC 1993 "Cellular adenomatoid nodules" of the thyroid: review of 219 fine-needle aspirates. Diagn Cytopathol 9:581-589
188. Silverman JF, West RL, Finley JL, Larkin EW, Park HK, Swanson MS, Fore WW 1986 Fine-needle aspiration vs. large-needle biopsy or cutting biopsy in evaluation of thyroid nodules. Diagn Cytopathol 2:25-30
189. Tangpricha V, Chen BJ, Swan NC, Sweeney AT, de las Morenas A, Safer JD 2001 Twenty-one-gauge needles provide more cellular samples than twenty-five-gauge needles in fine-needle aspiration biopsy of the thyroid but may not provide increased diagnostic accuracy. Thyroid 11:973-976
190. Leenhardt L, Hejblum G, Franc B, Fediaevsky LD, Delbot T, Le Guillouzic D, Menegaux F, Guillausseau C, Hoang C, Turpin G, Aurengo A 1999 Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 84:24-28
191. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ 1998 Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid 8:283-289
192. Rehak NN, Oertel YC, Herp A, Chiang BT, Csako G 1993 Biochemical analysis of thyroid cyst fluid obtained by fine-needle aspiration. Arch Pathol Lab Med 117:625-630
193. Morita M, Noguchi S, Kawamoto H, Tajiri J, Tamaru M, Murakami N 1994 Thyroglobulin and lactic dehydrogenase isozymes in cystic fluid of thyroid nodules. Endocr J 41:227-233
194. Rosen IB, Provias JP, Walfish PG 1986 Pathologic nature of cystic thyroid nodules selected for surgery by needle aspiration biopsy. Surgery 100:606-613
195. los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL 1990 Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med 150:1422-1427
196. Hatabu H, Kasagi K, Yamamoto K, Iida Y, Misaki T, Hidaka A, Shibata T, Shibata T, Shoji K, Higuchi K 1991 Cystic papillary carcinoma of the thyroid gland: a new sonographic sign. Clin Radiol 43:121-124
197. Sarda AK, Bal S, Dutta GS, Kapur MM 1988 Diagnosis and treatment of cystic disease of the thyroid by aspiration. Surgery 103: 593-596
198. McHenry CR, Slusarczyk SJ, Khiyami A 1999 Recommendations for management of cystic thyroid disease. Surgery 126:1167-1171
199. Lin JD, Huang BY 1998 Comparison of the results of diagnosis and treatment between solid and cystic well-differentiated thyroid carcinomas. Thyroid 8:661-666
200. Müller N, Cooperberg PL, Suen KC, Thorson SC 1985 Needle aspiration biopsy in cystic papillary carcinoma of the thyroid. AJR Am J Roentgenol 144:251-253
201. Pelizzo MR, Bernante P, Toniato A, Fassina A 1997 Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 83:653-655
202. Rojeski MT, Gharib H 1985 Nodular thyroid disease. Evaluation and management. N Engl J Med 313:428-436
203. Hagag P, Strauss S, Weiss M 1998 Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 8:989-995
204. Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, Perlmutter S 2000 The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 10:235-241
205. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941-1946
206. de Micco C, Zoro P, Garcia S, Skoog L, Tani EM, Carayon P, Henry JF 1994 Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine-needle aspiration biopsy. Eur J Endocrinol 131:474-479
207. Christensen L, Blichert-Toft M, Brandt M, Lange M, Bjerregaard SS, Ravnsbæk J, Mollerup CL, Strange L, Jensen F, Kirkegaard J, Sand HH, Sorensen SS, Feldt-Rasmussen U 2000 Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule. Clin Endocrinol (Oxf) 53:161-169
208. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A 1999 Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494-3502
209. Sebesta J, Brown T, Williard W, Dehart MJ, Aldous W, Kavolius J, Azarow K 2001 Does telomerase activity add to the value of fine needle aspirations in evaluating thyroid nodules? Am J Surg 181: 420-422
210. Siddiqui MT, Greene KL, Clark DP, Xydas S, Udelsman R, Smallridge RC, Zeiger MA, Saji M 2001 Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diagn Mol Pathol 10:123-129
211. Hintze G, Kobberling J 1992 Treatment of iodine deficiency goiter with iodine, levothyroxine or a combination of both. Thyroidology 4:37-40
212. Roti E, Uberti ED 2001 Iodine excess and hyperthyroidism. Thyroid 11:493-500
213. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G 1998 Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83-100
214. Harach HR, Williams ED 1995 Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol (Oxf) 43:701-706
215. Hansen JM, Kampmann J, Madsen SN, Skovsted L, Solgaard S, Grytter C, Grøntvedt T, Rasmussen SN 1979 L-Thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf) 10:1-6
216. Perrild H, Hansen JM, Hegedüs L, Rytter L, Holm B, Gundtofte E, Johansen K 1982 Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh) 100:382-387
217. Bongers H, Hotze LA, Schmitz R, Joseph K 1986 LT4-monopreparation vs. LT4-LT3-compound preparation in the treatment of diffuse endemic goitre. Acta Endocrinol (Copenh) 113:242-248
218. Wilders-Truschnig MM, Warnkross H, Leb G, Langsteger W, Eber O, Tiran A, Dobnig H, Passath A, Lanzer G, Drexhage HA 1993 The effect of treatment with levothyroxine or iodine on thyroid size and thyroid growth stimulating immunoglobulins in endemic goitre patients. Clin Endocrinol (Oxf) 39:281-286
219. Gullu S, Gurses MA, Baskal N, Uysal AR, Kamel AN, Erdogan G 1999 Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter. Endocr J 46:221-226
220. Peters H, Hackel D, Schleusener H 1997 [Treatment of euthyrold struma. Comparable volume reduction with 400 micrograms iodine, 100 micrograms levothyroxine combined with 100 micrograms iodine or individually dosed levothyroxine]. Med Klin 92: 63-67
221. Kreissl M, Tiemann M, Hanscheid H, Rendl J, Reiners C 2001 [Comparison of the effectiveness of two different dosages of levothyroxine-iodide combinations for the therapy of euthyroid diffuse goiter.] Dtsch Med Wochenschr 126:227-231
222. Schumm-Draeger PM 1993 [Drug therapy of goiter. Iodine, thyroid hormones or combined therapy.] Z Gesamte Inn Med 48:592-598
223. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G 1997 Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691-697
224. Wesche MF, Tiel-Van Buul MM, Lips P, Smits NJ, Wiersinga WM 2001 A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998-1005
225. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC 1992 Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 37:500-503
226. Solomon BL, Wartofsky L, Burman KD 1993 Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 3:17-23
227. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY 1996 Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278-4289
228. Faber J, Galloe AM 1994 Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350-356
229. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252
230. Tenerz A, Forberg R, Jansson R 1990 Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med 228:229-233
231. Bonnema SJ, Bennedbæk FN, Hegedüs L2001 [Danish endocrinologists' examination and treatment of non-toxic multinodular goiter. A questionnaire study]. Ugeskr Laeger 163:1265-1269
232. al Suliman NN, Ryttov NF, Qvist N, Blichert-Toft M, Graversen HP 1997 Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur J Surg 163:13-20
233. Thomusch O, Machens A, Sekulla C, Ukkat J, Lippert H, Gastinger I, Dralle H 2000 Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335-1341
234. Abdel Rahim AA, Ahmed ME, Hassan MA 1999 Respiratory complications after thyroidectomy and the need for tracheostomy in patients with a large goitre. Br J Surg 86:88-90
235. Maruotti RA, Zannini P, Viani MP, Voci C, Pezzuoli G 1991 Surgical treatment of substernal goiters. Int Surg 76:12-17
236. Torre G, Borgonovo G, Amato A, Arezzo A, Ansaldo G, De Negri A, Ughe M, Mattioli F 1995 Surgical management of substernal goiter: analysis of 237 patients. Am Surg 61:826-831
237. Vadasz P, Kotsis L 1998 Surgical aspects of 175 mediastinal goiters. Eur J Cardiothorac Surg 14:393-397
238. Allo MD, Thompson NW 1983 Rationale for the operative management of substernal goiters. Surgery 94:969-977
239. Hegedüs L, Nygaard B, Hansen JM 1999 Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84:756-760
240. Röjdmark J, Järhult J 1995 High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725-727
241. Berghout A, Wiersinga WM, Drexhage HA, van Trotsenburg P, Smits NJ, van der Gaag RD, Touber JL 1989 The long-term outcome of thyroidectomy for sporadic non-toxic goitre. Clin Endocrinol (Oxf) 31:193-199
242. Geerdsen JP, Frølund L 1986 Thyroid function after surgical treatment of nontoxic goitre. A randomized study of postoperative thyroxine administration. Acta Med Scand 220:341-345
243. Bistrup C, Nielsen JD, Gregersen G, Franch P 1994 Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 40:323-327
244. Miccoli P, Antonelli A, Iacconi P, Alberti B, Gambuzza C, Baschieri L 1993 Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097-1101
245. Feldkamp J, Seppel T, Becker A, Klisch A, Schlaghecke R, Goretzki PE, Roher HD 1997 Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21:10-14
246. Seiler CA, Glaser C, Wagner HE 1996 Thyroid gland surgery in an endemic region. World J Surg 20:593-596
247. Reeve TS, Delbridge L, Cohen A, Crummer P 1987 Total thyroidectomy. The preferred option for multinodular goiter. Ann Surg 206:782-786
248. Mishra A, Agarwal A, Agarwal G, Mishra SK 2001 Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg 25:307-310
249. Pappalardo G, Guadalaxara A, Frattaroli FM, Illomei G, Falaschi P 1998 Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 164:501-506
250. Hisham AN, Azlina AF, Aina EN, Sarojah A 2001 Total thyroidectomy: the procedure of choice for multinodular goitre. Eur J Surg 167:403-405
251. Hermus AR, Huysmans DA 1998 Treatment of benign nodular thyroid disease. N Engl J Med 338:1438-1447
252. Hegedüs L, Hansen BM, Knudsen N, Hansen JM 1988 Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. Br Med J 297:661-662
253. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Søe-Jensen P, Hansen JM 1993 Radioiodine treatment of multinodular non-toxic goitre. Br Med J 307:828-832
254. Le Moli R, Wesche MF, Tiel-Van Buul MM, Wiersinga WM 1999 Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf) 50:783-789
255. Wesche MF, Buul MM, Smits NJ, Wiersinga WM 1995 Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 132:86-87
256. Howarth DM, Epstein MT, Thomas PA, Allen LW, Akerman R, Lan L 1997 Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine. Eur J Nucl Med 24:1465-1469
257. Sabri O, Zimny M, Schreckenberger M, Meyer-Oelmann A, Reinartz P, Buell U 2000 Does thyroid stunning exist? A model with benign thyroid disease. Eur J Nucl Med 27:1591-1597
258. Bonnema SJ, Knudsen DU, Bertelsen H, Mortensen J, Andersen PB, Bastholt L, Hegedüs L 2002 Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging. Thyroid 12:313-317
259. Hegedüs L, Bennedbæk FN 1997 Radioiodine for non-toxic diffuse goitre. Lancet 350:409-410
260. Nygaard B, Faber J, Veje A, Hansen JE 1997 Thyroid volume and function after 131I treatment of diffuse non-toxic goitre. Clin Endocrinol (Oxf) 46:493-496
261. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Hansen BM, Søe-Jensen P, Hansen JM 1995 Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. J Intern Med 238:491-497
262. Verelst J, Bonnyns M, Glinoer D 1990 Radioiodine therapy in voluminous multinodular non-toxic goitre. Acta Endocrinol (Copenh) 122:417-421
263. Berg GE, Michanek AM, Holmberg EC, Fink M 1996 Iodine-131 treatment of hyperthyroidism: significance of effective half- life measurements. J Nucl Med 37:228-232
264. Kok SW, Smit JW, de Craen AJ, Goslings BM, Eck-Smit BL, Romijn JA 2000 Clinical outcome after standardized vs. dosimetric radioiodine treatment of hyperthyroidism: an equivalence study. Nucl Med Commun 21:1071-1078
265. Jarløv AE, Hegedüs L, Kristensen LØ, Nygaard B, Hansen JM 1995 Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile? Clin Endocrinol (Oxf) 43:325-329
266. Khandani A, Schicha H 1999 [Two-step radioiodine therapy in benign thyroid diseases during a single hospital visit-observations on 100 patients.] Nuklearmedizin 38:140-143
267. Van Isselt JW, de Klerk JM, Koppeschaar HP, Van Rijk PP 2000 Iodine-131 uptake and turnover rate vary over short intervals in Graves' disease. Nucl Med Commun 21:609-616
268. Traino AC, Di Martino F, Lazzeri M, Stabin MG 2000 Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 45:121-129
269. Nygaard B, Hegedüs L, Ulriksen P, Nielsen KG, Hansen JM 1999 Radioiodine therapy for multinodular toxic goiter. Arch Intern Med 159:1364-1368
270. Huysmans DA, Nieuwlaat W, Erdtsieck J, Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodine uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596
271. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA 2001 Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 86:5330-5336
272. Nygaard B, Faber J, Hegedüs L 1994 Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Clin Endocrinol (Oxf) 41:715-718
273. Huysmans AK, Hermus RM, Edelbroek MA, Tjabbes T, Oostdijk W, Ross HA, Corstens FH, Kloppenborg PW 1997 Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid 7:535-539
274. Nygaard B, Metcalfe RA, Phipps J, Weetman AP, Hegedüs L 1999 Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter. J Endocrinol Invest 22: 481-485
275. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P 1999 Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353: 2111-2115
276. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris III BS, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice Jr JD 1998 Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280:347-355
277. Hall P, Berg G, Bjelkengren G, Boice Jr JD, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J, Wiklund K 1992 Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 50:886-890
278. Angusti T, Codegone A, Pellerito R, Favero A 2000 Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism. J Nucl Med 41:1006-1009
279. Huysmans DA, Buijs WC, van de Ven MT, van den Broek WJ, Kloppenborg PW, Hermus AR, Corstens FH 1996 Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nucl Med 37:2072-2079
280. Miller MR, Pincock AC, Oates GD, Wilkinson R, Skene-Smith H 1990 Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. Q J Med 74:177-188
281. Nygaard B, Søes-Petersen U, Høilund-Carlsen PF, Veje A, Holst PE, Vestergaard A, Sølling K 1996 Improvement of upper airway obstruction after 131I-treatment of multinodular nontoxic goiter evaluated by flow volume loop curves. J Endocrinol Invest 19:71-75
282. Ferrari C, Reschini E, Paracchi A 1996 Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol 135:383-390
283. Hamburger JI 1987 The autonomously functioning thyroid nodule: Goetsch's disease. Endocr Rev 8:439-447
284. Wiener JD 1987 Plummer's disease: localized thyroid autonomy. J Endocrinol Invest 10:207-224
285. Michigishi T, Mizukami Y, Shuke N, Satake R, Noguchi M, Aburano T, Tonami N, Hisada K 1992 An autonomously functioning thyroid carcinoma associated with euthyroid Graves' disease. J Nucl Med 33:2024-2026
286. Liel Y 1999 The yield of adequate and conclusive fine-needle aspiration results in thyroid nodules is uniform across functional and goiter types. Thyroid 9:25-28
287. Hegedüs L, Veiergang D, Karstrup S, Hansen JM 1986 Compensated 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism. Acta Endocrinol (Copenh) 113:226-232
288. Nygaard B, Hegedüs L, Nielsen KG, Ulriksen P, Hansen JM 1999 Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf) 50:197-202
289. Mariotti S, Martino E, Francesconi M, Ceccarelli C, Grasso L, Lippi F, Baschieri L, Pinchera A 1986 Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid 'hot' nodule. Acta Endocrinol (Copenh) 113:500-507
290. Goldstein R, Hart IR 1983 Follow-up of solitary autonomous thyroid nodules treated with 131I. N Engl J Med 309:1473-1476
291. O'Brien T, Gharib H, Suman VJ, van Heerden JA 1992 Treatment of toxic solitary thyroid nodules: surgery vs. radioactive iodine. Surgery 112:1166-1170
292. Livraghi T, Paracchi A, Ferrari C, Bergonzi M, Garavaglia G, Raineri P, Vettori C 1990 Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Work in progress. Radiology 175:827-829
293. Goletti O, Monzani F, Caraccio N, Del Guerra P, Lippolis PV, Pucciarelli M, Seccia M, Carmassi F, Cavina E, Baschieri L 1992 Percutaneous ethanol injection treatment of autonomously functioning single thyroid nodules: optimization of treatment and short term outcome. World J Surg 16:784-789
294. Di Lelio A, Rivolta M, Casati M, Capra M 1995 Treatment of autonomous thyroid nodules: value of percutaneous ethanol injection. AJR Am J Roentgenol 164:207-213
295. Livraghi T, Paracchi A, Ferrari C, Reschini E, Macchi RM, Bonifacino A 1994 Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology 190: 529-533
296. Martino E, Murtas ML, Loviselli A, Piga M, Petrini L, Miccoli P, Pacini F 1992 Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules. Surgery 112: 1161-1164
297. Mazzeo S, Toni MG, De Gaudio C, Caramella D, Pinto F, Lencioni R, Sanguinetti F, Bartolozzi C 1993 Percutaneous injection of ethanol to treat autonomous thyroid nodules. AJR Am J Roentgenol 161:871-876
298. Monzani F, Goletti O, Caraccio N, Del Guerra P, Ferdeghini M, Pucci E, Baschieri L 1992 Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation. Clin Endocrinol (Oxf) 36:491-497
299. Özdemir H, Ilgit ET, Yucel C, Atilla S, Isik S, Cakir N, Gokcora N 1994 Treatment of autonomous thyroid nodules: safety and efficacy of sonographically guided percutaneous injection of ethanol. AJR Am J Roentgenol 163:929-932
300. Papini E, Panunzi C, Pacella CM, Bizzarri G, Fabbrini R, Petrucci L, Pisicchio G, Nardi F 1993 Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J Clin Endocrinol Metab 76:411-416
301. Lippi F, Ferrari C, Manetti L, Rago T, Santini F, Monzani F, Bellitti P, Papini E, Busnardo B, Angelini F, Pinchera A 1996 Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group. J Clin Endocrinol Metab 81:3261-3264
302. Monzani F, Caraccio N, Goletti O, Lippolis PV, Casolaro A, Del Guerra P, Cavina E, Miccoli P 1997 Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol (Oxf) 46:9-15
303. Nakada K, Katoh C, Kanegae K, Tsukamoto E, Itoh K, Tamaki N 1996 Percutaneous ethanol injection therapy for autonomously functioning thyroid nodule. Ann Nucl Med 10:171-176
304. Brkljacic B, Sucic M, Bozikov V, Hauser M, Hebrang A 2001 Treatment of autonomous and toxic thyroid adenomas by percutaneous ultrasound-guided ethanol injection. Acta Radiol 42: 477-481
305. Cerbone G, Spiezia S, Colao A, Marzullo P, Assanti AP, Lucci R, Zarrilli S, Siciliani M, Fenzi G, Lombardi G 1999 Percutaneous ethanol injection under Power Doppler ultrasound assistance in the treatment of autonomously functioning thyroid nodules. J Endocrinol Invest 22:752-759
306. Komorowski J, Kuzdak K, Pomorski L, Bartos M, Stepien H 1998 Percutaneous ethanol injection in treatment of benign nonfunctional and hyperfunctional thyroid nodules. Cytobios 95:143-150
307. Mincheva L, Simeonov S, Troev D, Mitkov M, Pavlova M, Iliev D, Botushanov N 1997 Percutaneous ethanol sclerotherapy of autonomous thyroid nodules: preliminary results. Folia Med (Plovdiv) 39:49-54
308. Monzani F, Caraccio N, Goletti O, Casolaro A, Lippolis PV, Cavina E, Miccoli P 1998 Treatment of hyperfunctioning thyroid nodules with percutaneous ethanol injection: eight years' experience. Exp Clin Endocrinol Diabetes 106(Suppl 4):S54-S58
309. Sardanelli F, Giordano GD, Melani E, Parodi RC, Giusti M, Garlaschi G 1997 Magnetic resonance evaluation of autonomous thyroid nodules treated by percutaneous ethanol injection. MAGMA 5:267-274
310. Spiezia S, Cerbone G, Assanti AP, Colao A, Siciliani M, Lombardi G 2000 Power Doppler ultrasonographic assistance in percutaneous ethanol injection of autonomously functioning thyroid nodules. J Ultrasound Med 19:39-46
311. Tarantino L, Giorgio A, Mariniello N, de Stefano G, Perrotta A, Aloisio V, Tamasi S, Forestieri MC, Esposito F, Esposito F, Finizia L, Voza A 2000 Percutaneous ethanol injection of large autonomous hyperfunctioning thyroid nodules. Radiology 214:143-148
312. Bennedbæk FN, Karstrup S, Hegedüs L 1997 Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 136:240-250
313. Monzani F, Del Guerra P, Caraccio N, Casolaro A, Lippolis PV, Goletti O 1997 Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma. J Endocrinol Invest 20:294-298
314. Miccoli P, Bendinelli C, Monzani F 1998 Surgical aspects of thyroid nodules previously treated by ethanol injection. Exp Clin Endocrinol Diabetes 106(Suppl 4):S75-S77
315. Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, Pacella S, Papini E 2000 Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217:673-677
316. Zelmanovitz F, Genro S, Gross JL 1998 Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881-3885
317. Gharib H, Mazzaferri EL 1998 Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 128:386-394
318. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM 1998 Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780-783
319. Csako G, Byrd D, Wesley RA, Sarlis NJ, Skarulis MC, Nieman LK, Pucino F 2000 Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis. Medicine (Baltimore) 79:9-26
320. Bennedbæk FN, Nielsen LK, Hegedüs L 1998 Effect of percutaneous ethanol injection therapy vs. suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab 83:830-835
321. Castro MR, Caraballo PJ, Morris JC 2002 Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154-4159
322. Bennedbæk FN, Perrild HJ, Hegedüs L 1999 [Investigation and treatment of solitary thyroid gland nodules by Danish endocrinologists. A questionnaire study.] Ugeskr Laeger 161:1264-1269
323. Wadström C, Zedenius J, Guinea A, Reeve T, Delbridge L 1999 Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy? Aust N Z J Surg 69:34-36
324. Liu Q, Djuricin G, Prinz RA 1998 Total thyroidectomy for benign thyroid disease. Surgery 123:2-7
325. Krouse RS, McCarty T, Weiss LM, Wagman LD 2000 Postoperative suppressive therapy for thyroid adenomas. Am Surg 66:751-755
326. Songun I, Kievit J, Wobbes T, Peerdeman A, van de Velde CJ 1999 Extent of thyroidectomy in nodular thyroid disease. Eur J Surg 165:839-842
327. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R 1998 The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320-330
328. Bellantone R, Lombardi CP, Raffaelli M, Rubino F, Boscherini M, Perilli W 1999 Minimally invasive, totally gasless video-assisted thyroid lobectomy. Am J Surg 177:342-343
329. Bliss RD, Gauger PG, Delbridge LW 2000 Surgeon's approach to the thyroid gland: surgical anatomy and the importance of technique. World J Surg 24:891-897
330. Gagner M, Inabnet III WB 2001 Endoscopic thyroidectomy for solitary thyroid nodules. Thyroid 11:161-163
331. Bennedbæk FN, Hegedüs L 1999 Percutaneous ethanol injection therapy in benign solitary solid cold thyroid nodules: a randomized trial comparing one injection with three injections. Thyroid 9:225-233
332. Caraccio N, Goletti O, Lippolis PV, Casolaro A, Cavina E, Miccoli P, Monzani F 1997 Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years' experience. Thyroid 7:699-704
333. Zingrillo M, Collura D, Ghiggi MR, Nirchio V, Trischitta V 1998 Treatment of large cold benign thyroid nodules not eligible for surgery with percutaneous ethanol injection. J Clin Endocrinol Metab 83:3905-3907
334. Døssing H, Bennedbæk FN, Karstrup S, Hegedüs L 2002 Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation-initial experience. Radiology 225:53-57
335. Lo GP, Ting W 1983 Method for biopsy of the wall of a thyroid cyst. Am J Surg 146:383-384
336. Clark OH, Okerlund MD, Cavalieri RR, Greenspan FS 1979 Diagnosis and treatment of thyroid, parathyroid, and thyroglossal duct cysts. J Clin Endocrinol Metab 48:983-988
337. Jensen F, Rasmussen SN 1976 The treatment of thyroid cysts by ultrasonically guided fine needle aspiration. Acta Chir Scand 142: 209-211
338. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M 1994 Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 18:495-498
339. Pacini F, Antonelli A, Lari R, Gasperini L, Baschieri L, Pinchera A 1985 Unsuspected parathyroid cysts diagnosed by measurement of thyroglobulin and parathyroid hormone concentrations in fluid aspirates. Ann Intern Med 102:793-794
340. McCowen KD, Reed JW, Fariss BL 1980 The role of thyroid therapy in patients with thyroid cysts. Am J Med 68:853-855
341. Meko JB, Norton JA 1995 Large cystic/solid thyroid nodules: a potential false-negative fine-needle aspiration. Surgery 118:996-1003
342. Abbas G, Heller KS, Khoynezhad A, Dubner S, Sznyter LA 2001 The incidence of carcinoma in cytologically benign thyroid cysts. Surgery 130:1035-1038
343. Bean WJ 1981 Renal cysts: treatment with alcohol. Radiology 138: 329-331
344. Ryan WG, Schwartz TB, Harris J 1983 Sclerosis of thyroid cyst with tetracycline. N Engl J Med 308:157
345. Edmonds CJ, Tellez M 1987 Treatment of thyroid cysts by aspiration and injection of sclerosant. Br Med J (Clin Res Ed) 295:529
346. Treece GL, Georgitis WJ, Hofeldt FD 1983 Resolution of recurrent thyroid cysts with tetracycline instillation. Arch Intern Med 143: 2285-2287
347. DeYoung JP, Kahn A, Lerman S, Ferenczy AS 1986 Tetracycline instillation for recurrent cystic thyroid nodules. Can J Surg 29: 118-119
348. Goldfarb WB, Bigos ST, Nishiyama RH 1987 Percutaneous tetracycline instillation for sclerosis of recurrent thyroid cysts. Surgery 102:1096-1100
349. Hegedüs L, Hansen JM, Karstrup S, Torp-Pedersen S, Juul N 1988 Tetracycline for sclerosis of thyroid cysts. A randomized study. Arch Intern Med 148:1116-1118
350. Lee JK, Tai FT, Lin HD, Chou YH, Kaplan MM, Ching KN 1989 Treatment of recurrent thyroid cysts by injection of tetracycline or minocycline. Arch Intern Med 149:599-601
351. Rajatanavin R, Chailurkit L, Chiemchanya S 1994 The efficacy of percutaneous tetracycline instillation for sclerosis of recurrent thyroid cysts: a multivariate analysis. J Endocrinol Invest 17:123-125
352. Garg MK, Satija L, Khanna SK, Saini JS 2000 Intracystic tetracycline therapy for hypofunctioning cystic thyroid nodules. J Assoc Physicians India 48:891-894
353. Verde G, Papini E, Pacella CM, Gallotti C, Delpiano S, Strada S, Fabbrini R, Bizzarri G, Rinaldi R, Panunzi C 1994 Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf) 41:719-724
354. Yasuda K, Ozaki O, Sugino K, Yamashita T, Toshima K, Ito K, Harada T 1992 Treatment of cystic lesions of the thyroid by ethanol instillation. World J Surg 16:958-961
355. Antonelli A, Campatelli A, Di Vito A, Alberti B, Baldi V, Salvioni G, Fallahi P, Baschieri L 1994 Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. Clin Investig 72:971-974
356. Cho YS, Lee HK, Ahn IM, Lim SM, Kim DH, Choi CG, Suh DC 2000 Sonographically guided ethanol sclerotherapy for benign thyroid cysts: results in 22 patients. AJR Am J Roentgenol 174:213-216
357. Monzani F, Lippi F, Goletti O, Del Guerra P, Caraccio N, Lippolis PV, Baschieri L, Pinchera A 1994 Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts. J Clin Endocrinol Metab 78:800-802
358. Zingrillo M, Torlontano M, Ghiggi MR, D'Aloiso L, Nirchio V, Bisceglia M, Liuzzi A 1996 Percutaneous ethanol injection of large thyroid cystic nodules. Thyroid 6:403-408
359. Iacconi P, Spinelli C, Monzani F, Miccoli P 1996 Percutaneous ethanol injection for thyroid cysts: a word of caution. Clin Endocrinol (Oxf) 44:126